✦ LIBER ✦

A Multicenter Randomized Clinical Trial Evaluating Interleukin-2 Activated Hematopoietic Stem Cell Transplantation and Post-transplant IL-2 for High Risk Breast Cancer Patients

✍ Scribed by Claudine Isaacs; Rebecca Slack; Edmund Gehan; Karen Ballen; Ralph Boccia; Ellen Areman; Ruthie Kramer; Daniel F. Hayes; Herbert Herscowitz; Marc Lippman

Book ID: 106376853
Publisher: Springer US
Year: 2005
Tongue: English
Weight: 290 KB
Volume: 93
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-005-4445-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunotherapy with interleukin-2 and α-i

Immunotherapy with interleukin-2 and α-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer

✍ Meehan, K R; Arun, B; Gehan, E A; Berberian, B; Sulica, V; Areman, E M; Mazumder 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB

Interleukin-2 and granulocyte–macrophage

Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

✍ Yee Chung Cheng; Gabriela Rondón; Leah F. Sanchez; John D. McMannis; Daniel R. C 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 210 KB